Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
(Q61646585)
scientific article published on 01 January 2007
scientific article published on 01 January 2007
Language:
Current Data About
Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
other details
description | scientific article published on 01 January 2007 |
External Links
(P356) |
10.1002/ART.22289
|
(P698) |
17195236
|
(P6179) |
1025661593
|